Abraham Germansderfer

Title: Abraham Germansderfer: Innovator in Immune Cell Transduction

Introduction

Abraham Germansderfer is a notable inventor based in Boca Raton, FL (US). He has made significant contributions to the field of immunology through his innovative work on transducing immune cells. His research focuses on enhancing the efficiency of gene expression in immune cells, particularly T cells.

Latest Patents

Germansderfer holds a patent for "Methods for transducing immune cells." This patent outlines improved methods for transducing immune cells, such as T cells, using retroviral vectors to express exogenous gene products, including chimeric antigen receptors (CARs). The methods described in the patent aim to increase transduction efficiency, thereby enhancing the percentage of immune cells in a population that express the exogenous gene product. The patent also includes associated cells, cell populations, compositions, and methods of use.

Career Highlights

Abraham Germansderfer is currently associated with Allogene Therapeutics, Inc., where he continues to advance his research in the field of immunotherapy. His work is pivotal in developing new therapeutic strategies for treating various diseases, including cancer.

Collaborations

Germansderfer collaborates with notable colleagues such as Todd Luman and Josergio Zaragoza. Their combined expertise contributes to the innovative research environment at Allogene Therapeutics, Inc.

Conclusion

Abraham Germansderfer is a key figure in the advancement of immune cell transduction technologies. His patent and ongoing work at Allogene Therapeutics, Inc. highlight his commitment to improving therapeutic outcomes in immunology.